SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
CBRE Group, Inc. (CBRE) trades at a trailing P/E of 36.1, forward P/E of 19.6. Trailing earnings yield is 2.77%, forward earnings yield 5.11%. PEG 1.60. Graham Number is $53.32.
Criteria proven by this page:
- VALUE (49/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 19.6 (down from trailing 36.1) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.60 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 2.77% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 5.11% as earnings recover.
- Analyst consensus target $185.67 (+26.2% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 54/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
49/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CBRE
Valuation Multiples
P/E (TTM)36.1
Forward P/E19.6
PEG Ratio1.60
Forward PEG0.21
P/B Ratio4.71
P/S Ratio1.02
EV/EBITDA20.0
Per Share Data
EPS (TTM)$3.90
Forward EPS (Est.)$7.51
Book Value / Share$32.42
Revenue / Share$136.59
FCF / Share$4.02
Yields & Fair Value
Earnings Yield2.77%
Forward Earnings Yield5.11%
Dividend Yield0.00%
Graham Number$53.32
SharesGrow IV$102.48 (-30.3%)
Analyst Target$185.67 (+26.2%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
18.5 |
4.33 |
3.50 |
0.61 |
- |
| 2017 |
21.1 |
1.03 |
3.64 |
0.79 |
- |
| 2018 |
12.8 |
0.25 |
2.75 |
0.64 |
- |
| 2019 |
16.0 |
0.73 |
3.30 |
0.86 |
- |
| 2020 |
28.0 |
-0.68 |
2.97 |
0.88 |
- |
| 2021 |
19.8 |
0.14 |
4.27 |
1.31 |
- |
| 2022 |
17.7 |
-0.86 |
3.16 |
0.81 |
- |
| 2023 |
29.1 |
-1.09 |
3.47 |
0.90 |
- |
| 2024 |
41.5 |
-33.19 |
4.77 |
1.12 |
- |
| 2025 |
41.4 |
1.82 |
5.40 |
1.18 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.69 |
$13.07B |
$571.97M |
4.4% |
| 2017 |
$2.05 |
$14.21B |
$691.48M |
4.9% |
| 2018 |
$3.10 |
$21.34B |
$1.06B |
5% |
| 2019 |
$3.77 |
$23.89B |
$1.28B |
5.4% |
| 2020 |
$2.22 |
$23.83B |
$751.99M |
3.2% |
| 2021 |
$5.41 |
$27.75B |
$1.84B |
6.6% |
| 2022 |
$4.29 |
$30.83B |
$1.41B |
4.6% |
| 2023 |
$3.15 |
$31.95B |
$986M |
3.1% |
| 2024 |
$3.14 |
$35.77B |
$968M |
2.7% |
| 2025 |
$3.85 |
$40.55B |
$1.16B |
2.9% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$7.51 |
$7.16 – $7.81 |
$45.76B |
$43.19B – $47.64B |
7 |
| 2027 |
$8.69 |
$8.21 – $9.30 |
$49.9B |
$46.23B – $53.25B |
7 |
| 2028 |
$9.83 |
$8.51 – $12.58 |
$51.42B |
$50.41B – $52.44B |
5 |
| 2029 |
$11.31 |
$10.41 – $11.99 |
$57.31B |
$53.83B – $59.96B |
1 |
| 2030 |
$13.65 |
$12.57 – $14.47 |
$61.26B |
$57.54B – $64.1B |
1 |
